Dishman Pharmaceuticals and Chemicals Limited Sustainability Profile
Dishman Pharmaceuticals and Chemicals Limited, commonly referred to as Dishman, is a prominent player in the pharmaceutical and chemical industry, headquartered in India. Established in 1983, the company has made significant strides in the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and contract research services, catering to a global clientele. With major operational regions across Europe, North America, and Asia, Dishman is renowned for its innovative approach to custom synthesis and its commitment to quality. The company’s core offerings include a diverse range of APIs and specialty chemicals, distinguished by their adherence to stringent regulatory standards and a focus on sustainability. Dishman’s market position is bolstered by its state-of-the-art facilities and a strong emphasis on research and development, making it a trusted partner in the pharmaceutical sector.
DitchCarbon Score
How does Dishman Pharmaceuticals and Chemicals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dishman Pharmaceuticals and Chemicals Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dishman Pharmaceuticals and Chemicals Limited's reported carbon emissions
Dishman Pharmaceuticals and Chemicals Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Dishman Pharmaceuticals does not inherit emissions data from any parent or related organizations, nor does it participate in any recognised climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the pharmaceutical and chemicals industry, companies are increasingly expected to set ambitious climate commitments and reduce their carbon footprints. However, without specific data or commitments, it is unclear how Dishman Pharmaceuticals aligns with these industry standards.
How Carbon Intensive is Dishman Pharmaceuticals and Chemicals Limited's Industry?
How Carbon Intensive is Dishman Pharmaceuticals and Chemicals Limited's Location?
Dishman Pharmaceuticals and Chemicals Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dishman Pharmaceuticals and Chemicals Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
